195 related articles for article (PubMed ID: 27301456)
1. A phenome-wide association study of a lipoprotein-associated phospholipase A2 loss-of-function variant in 90 000 Chinese adults.
Millwood IY; Bennett DA; Walters RG; Clarke R; Waterworth D; Johnson T; Chen Y; Yang L; Guo Y; Bian Z; Hacker A; Yeo A; Parish S; Hill MR; Chissoe S; Peto R; Cardon L; Collins R; Li L; Chen Z;
Int J Epidemiol; 2016 Oct; 45(5):1588-1599. PubMed ID: 27301456
[TBL] [Abstract][Full Text] [Related]
2. Effects of overweight and the PLA2G7 V279F polymorphism on the association of age with systolic blood pressure.
Kim M; Kim M; Yoo HJ; Jang HY; Lee SH; Lee JH
PLoS One; 2017; 12(3):e0173611. PubMed ID: 28334001
[TBL] [Abstract][Full Text] [Related]
3. Correlations Between LP-PLA2 Gene Polymorphisms and Susceptibility and Severity of Acute Pancreatitis in a Chinese Population.
Ma M; Zhai CX; Sun CX
Genet Test Mol Biomarkers; 2017 Apr; 21(4):206-212. PubMed ID: 28332853
[TBL] [Abstract][Full Text] [Related]
4. Association of Serum Lipoprotein-Associated Phospholipase A2 and A379V Gene Polymorphisms with Carotid Plaques.
Wu C; Zhou T; Zhou Y; Han W
Genet Test Mol Biomarkers; 2020 Mar; 24(3):131-137. PubMed ID: 32109154
[No Abstract] [Full Text] [Related]
5. PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry.
Casas JP; Ninio E; Panayiotou A; Palmen J; Cooper JA; Ricketts SL; Sofat R; Nicolaides AN; Corsetti JP; Fowkes FG; Tzoulaki I; Kumari M; Brunner EJ; Kivimaki M; Marmot MG; Hoffmann MM; Winkler K; März W; Ye S; Stirnadel HA; Boekholdt SM; Khaw KT; Humphries SE; Sandhu MS; Hingorani AD; Talmud PJ
Circulation; 2010 Jun; 121(21):2284-93. PubMed ID: 20479152
[TBL] [Abstract][Full Text] [Related]
6. Effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity in Japanese dyslipidemic patients, with exploratory analysis of a PLA2G7 gene polymorphism of Val279Phe.
Daida H; Iwase T; Yagi S; Ando H; Nakajima H
Circ J; 2013; 77(6):1518-25. PubMed ID: 23439604
[TBL] [Abstract][Full Text] [Related]
7. Effects of A379V variant of the Lp-PLA 2 gene on Lp-PLA 2 activity and markers of oxidative stress and endothelial function in Koreans.
Chae JS; Kwak JH; Kim M; Shin KH; Lee SH; Jeong TS; Lee JH
J Thromb Thrombolysis; 2014 Nov; 38(4):477-84. PubMed ID: 24682749
[TBL] [Abstract][Full Text] [Related]
8. Association of PLA2G7 gene polymorphisms with ischemic stroke in northern Chinese Han population.
Liu X; Zhu RX; Tian YL; Li Q; Li L; Deng SM; He ZY
Clin Biochem; 2014 Apr; 47(6):404-8. PubMed ID: 24463064
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein-associated phospholipase A2 gene V279F polymorphisms and coronary heart disease: a meta-analysis.
Zheng GH; Chen HY; Xiong SQ; Chu JF
Mol Biol Rep; 2011 Aug; 38(6):4089-99. PubMed ID: 21107710
[TBL] [Abstract][Full Text] [Related]
10. Nonsynonymous polymorphisms in PLA2G7 gene are associated with the risk of coronary heart disease in a southern Chinese population.
Hong M; Zhang M; Lu X
Mamm Genome; 2015 Apr; 26(3-4):191-9. PubMed ID: 25690150
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
[TBL] [Abstract][Full Text] [Related]
12. The association between the D166E polymorphism of the lipoprotein associated phospholipase A2 and risk of myocardial infarction.
Zhang MM; Zhang CG; Yang CJ; Zhao P; Li YL
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3960-3966. PubMed ID: 31115024
[TBL] [Abstract][Full Text] [Related]
13. Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study.
Hou L; Chen S; Yu H; Lu X; Chen J; Wang L; Huang J; Fan Z; Gu D
Hum Genet; 2009 Feb; 125(1):11-20. PubMed ID: 19034521
[TBL] [Abstract][Full Text] [Related]
14. Genetic invalidation of Lp-PLA
Gregson JM; Freitag DF; Surendran P; Stitziel NO; Chowdhury R; Burgess S; Kaptoge S; Gao P; Staley JR; Willeit P; Nielsen SF; Caslake M; Trompet S; Polfus LM; Kuulasmaa K; Kontto J; Perola M; Blankenberg S; Veronesi G; Gianfagna F; Männistö S; Kimura A; Lin H; Reilly DF; Gorski M; Mijatovic V; ; Munroe PB; Ehret GB; ; Thompson A; Uria-Nickelsen M; Malarstig A; Dehghan A; ; Vogt TF; Sasaoka T; Takeuchi F; Kato N; Yamada Y; Kee F; Müller-Nurasyid M; Ferrières J; Arveiler D; Amouyel P; Salomaa V; Boerwinkle E; Thompson SG; Ford I; Wouter Jukema J; Sattar N; Packard CJ; Shafi Majumder AA; Alam DS; Deloukas P; Schunkert H; Samani NJ; Kathiresan S; ; Nordestgaard BG; Saleheen D; Howson JM; Di Angelantonio E; Butterworth AS; Danesh J;
Eur J Prev Cardiol; 2017 Mar; 24(5):492-504. PubMed ID: 27940953
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.
Yeo A; Li L; Warren L; Aponte J; Fraser D; King K; Johansson K; Barnes A; MacPhee C; Davies R; Chissoe S; Tarka E; O'Donoghue ML; White HD; Wallentin L; Waterworth D
PLoS One; 2017; 12(7):e0182115. PubMed ID: 28753643
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease.
Maiolino G; Lenzini L; Pedon L; Cesari M; Seccia TM; Frigo AC; Rossitto G; Caroccia B; Rossi GP
J Cardiovasc Med (Hagerstown); 2015 Jan; 16(1):29-36. PubMed ID: 24732951
[TBL] [Abstract][Full Text] [Related]
17. Carriage of the V279F null allele within the gene encoding Lp-PLA₂ is protective from coronary artery disease in South Korean males.
Jang Y; Waterworth D; Lee JE; Song K; Kim S; Kim HS; Park KW; Cho HJ; Oh IY; Park JE; Lee BS; Ku HJ; Shin DJ; Lee JH; Jee SH; Han BG; Jang HY; Cho EY; Vallance P; Whittaker J; Cardon L; Mooser V
PLoS One; 2011 Apr; 6(4):e18208. PubMed ID: 21490708
[TBL] [Abstract][Full Text] [Related]
18. Genetic deficiency of plasma lipoprotein-associated phospholipase A2 (PLA2G7 V297F null mutation) and risk of Alzheimer's disease in Japan.
Koshy B; Miyashita A; St Jean P; Stirnadel H; Kaise T; Rubio JP; Mooser V; Kuwano R; Irizarry MC
J Alzheimers Dis; 2010; 21(3):775-80. PubMed ID: 20634581
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein-associated phospholipase A2 regulates macrophage apoptosis via the Akt and caspase-7 pathways.
Maeda T; Takeuchi K; Xiaoling P; P Zankov D; Takashima N; Fujiyoshi A; Kadowaki T; Miura K; Ueshima H; Ogita H
J Atheroscler Thromb; 2014; 21(8):839-53. PubMed ID: 24717759
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans.
Perrot N; Thériault S; Rigade S; Chen HY; Dina C; Martinsson A; Boekholdt SM; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Engert JC; Wareham NJ; Clavel MA; Pibarot P; Smith JG; Schott JJ; Mathieu P; Bossé Y; Thanassoulis G; Arsenault BJ
Heart; 2020 Sep; 106(18):1407-1412. PubMed ID: 32636298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
